PDCD1 and neoplasm: Indeed, tumors derived from obese mice were rejected in 15 of 20 secondary recipients treated with anti-PD-1, whereas tumors derived from lean mice were relatively insensitive to anti-PD-1, with only 5 of 20 mice rejecting their tumor (Fig. 6B, C, Supplementary Fig. S9).